WO1999037243A1 - A method for making an extensible stent from sheet material - Google Patents

A method for making an extensible stent from sheet material Download PDF

Info

Publication number
WO1999037243A1
WO1999037243A1 PCT/NL1999/000035 NL9900035W WO9937243A1 WO 1999037243 A1 WO1999037243 A1 WO 1999037243A1 NL 9900035 W NL9900035 W NL 9900035W WO 9937243 A1 WO9937243 A1 WO 9937243A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
fibers
reinforcing fibers
sheet
plastics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NL1999/000035
Other languages
English (en)
French (fr)
Inventor
Hendrik Glastra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIGITEC BV
Original Assignee
RIGITEC BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIGITEC BV filed Critical RIGITEC BV
Priority to JP2000528233A priority Critical patent/JP2002500921A/ja
Priority to DE69926603T priority patent/DE69926603T2/de
Priority to AU19865/99A priority patent/AU1986599A/en
Priority to EP99900719A priority patent/EP1049419B1/en
Publication of WO1999037243A1 publication Critical patent/WO1999037243A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/92Stents in the form of a rolled-up sheet expanding after insertion into the vessel, e.g. with a spiral shape in cross-section
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/04Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts comprising reinforcements only, e.g. self-reinforcing plastics
    • B29C70/28Shaping operations therefor
    • B29C70/30Shaping by lay-up, i.e. applying fibres, tape or broadsheet on a mould, former or core; Shaping by spray-up, i.e. spraying of fibres on a mould, former or core
    • B29C70/32Shaping by lay-up, i.e. applying fibres, tape or broadsheet on a mould, former or core; Shaping by spray-up, i.e. spraying of fibres on a mould, former or core on a rotating mould, former or core
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/04Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts comprising reinforcements only, e.g. self-reinforcing plastics
    • B29C70/28Shaping operations therefor
    • B29C70/54Component parts, details or accessories; Auxiliary operations, e.g. feeding or storage of prepregs or SMC after impregnation or during ageing
    • B29C70/545Perforating, cutting or machining during or after moulding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0091Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C2793/00Shaping techniques involving a cutting or machining operation
    • B29C2793/0045Perforating
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C53/00Shaping by bending, folding, twisting, straightening or flattening; Apparatus therefor
    • B29C53/56Winding and joining, e.g. winding spirally
    • B29C53/562Winding and joining, e.g. winding spirally spirally

Definitions

  • the invention relates to a method for making an extensible stent which is to be brought into a form- retaining state by curing.
  • Vasculair stents for locally reinforcing a body vessel, to be introduced by means of a catheter are brought into their final configuration by means of an extensible element at the distal end of this catheter whereafter irridiation with UV radiation initiates the curing of the plastics material are known from the prior art. Mentioned are the patent publications US-5.344.444 , US-5.464.419 , EP- 0 521 573 Bl en EP-0 617 930, all haviang the same inventor as the present one.
  • the invention aims to provide such a ethode.
  • the invention proposes a method for making an extensible stent which is brought in a form retaining state with predetermined final configuration by curing, in which one starts from a template with an outer configuration corresponding with the desired final configuration, winds this with sheet-shaped material made from coherent fibers which is either before or after the winding soaked with a plastics with a controlled initiated curing.
  • This plastics can be dissolved in a solvent whichthereafter is evaporated controllable by heating.
  • the method according to the invention is excellently suited to provide thereon a therapeutic active for a radiation emitting substance leads to the advantage that it is possible to implant it into a patient directly after the determination of shape and configuration of such a stent, so that the treatment can be started without any delay.
  • a sheet-shaped base material with metallic reinforcing fibers distributed therein With these simple measures which can be integrated simply in the fabrication process of the base material an increased strength of the material is obtained so that for a particular use it can have smaller dimensions, particularly a smaller thickness, in combination with a certain opaqueness for X-ray radiation so that not only the positioning but also the detection of a stent made from this material at a later moment becomes very easy.
  • Length, diameter and configuration of the fibers will, in a certain practical embodiment, be adapted to the use one has in view. Preferred embodiments are given in the claims 9 and 10.
  • the starting material for the fibers can be made radioactive by introducing a radio-active isotope in the melt thereof.
  • a radio-active isotope in the melt thereof.
  • the sheet-shaped starting material which comprises the fibers is preferrably made in the way as described in the claims 19-21.
  • the claimed exclusive rights also include a stent such as is subject of the claims 22-26.
  • the invention is elucidated on the hand of a drawing.
  • fig. 1 schematically the use of a template in the method according to the invention
  • fig. 2 in cross-section a preferred embodiment of a stent, obtained therewith
  • fig. 3 the use of a template to execute the method according to the invention in combination with the provision of openings in the surface of the stent obtained therewith
  • fig. 4 a side view of a stent, obtained in this way
  • fig. 5 a side view of a template and the stent formed thereon, having a tapering configuration
  • FIG. 6 a side view of a template with a stent made thereon in a configuration in which the ends of the stent have a greater diameter than the middle part thereof;
  • fig. 7 schematically and in top view sheet-shaped material to be used in the method according to the invention;
  • fig. 8 schematically and in perspective a stent made from this material;
  • fig. 9 schematically and in top view sheet-shaped material to be used in the method according to the invention according to a second embodiment;
  • fig. 10 schematically and in perspective view another embodiment of a stent obtained by using this material;
  • fig. 13 a fourth embodiment of the sheet-shaped starting material according to the invention; and fig.
  • the material After winding such a length of material on the template 2 that the wound cylinder 5 has obtained the desired thickness the material is cut-off and thereafter soaked in a plastics, which can be dissolved in a solvent of the kind known as such, the curing ofo the plastics can be initiated controllably by irradiation with UV-radiation.
  • a fiber material which is soaked in such a plastics before it is wound, but handling thereof is somewhat more difficult.
  • this stent of which the outer surface is still somewhat sticky, can be rolled in a therapeutic substance (aspirin, heparin, cocain) in powder form, which adheres to the outer surface and can easily be provided thereon in a controlled quantity. Controlled powdering is also possible.
  • a therapeutic substance aspirin, heparin, cocain
  • Controlled powdering is also possible.
  • the ends of a stent are more flexible than the middle part and according to the invention this can be obtained very simply by chosing a higher concentration of the plastics material in the end zones, indicated in fig. 2 with 6a and 6b, than in the middle zone 8.
  • a substance with a therapeutic action or a substance emitting radio-active radiation is provided not over the entire surface of the stent but only in a certain part thereof.
  • the method of the invention makes it easy to coat the, still sticky, outer surface of the stent with a substance with therapeutic action, not equally, but only selectively on certain surface parts.
  • the invention also gives the possibility to form openings on certain preferred places in the stent, said openings being filled with a substance with therapeutic action later-on. 5
  • fig. 3 shows, use a template 10 in which the stent 12, wound thereon, is pierced by pins, placed in rings, as indicated by 14, 16 en 18. After curing of the stent and the removal of the pins the stent 20 results within its body three rings of openings 14', 16', 18', corresponding with the rings of pins 14, 16 and 18.
  • FIG. 5 shows a somewhat tapering template 22 of which the left hand end 24a has a smaller diameter than the right hand end 24b; corresponding therewith the stent 26, obtained with this template, is also tapering; the left hand end 28a has a smaller diameter than the right hand end 28b.
  • This stent can be removed easily from the template 22.
  • FIG. 6 shows in side view such an embodiment of the method according to the invention: the template 30, as used, has ends 32a, 32b with a greater diameter than the middle part and corresponding therewith the stent 34, formed thereon, has ends 36a, 36b with a greater diameter than the middle part 38.
  • metallic reinforcing fibers into the sheet-shaped starting material.
  • These fibers are preferably made from titanium, generally from a "biocompatible" material . This introducing can be done during the grinding of the fibers or also during the intensive mixing of the pulp.
  • the length and the diameter of the fibers to be added can be chosen in dependance on the final use one has in mind.
  • the fibers can be supplied individually and incoherently but it is also possible to introduce them more or less coherently into the pulp, as will be described later on.
  • As a value for the minimum diameter to be used one thinks of 5 ⁇ m and as minimum length 1-2 mm, although the 6 dimensions are certainly not restrictive and particularly the minimum dimensions are only set by the possibility of handling the fibers.
  • the weight percentage of the fibers can be chosen independant from the aim one has in mind: a weight percentage of 10-20% is possible. Other values are also possible.
  • Fig. 7 shows a part of sheet material 42 with equally distributed metallic fibers 44 therein, which are, of course, shown only schematically.
  • the sheet 42 is cut up along the perpendicular crossing vertical cutting lines 46a, 46b, 46c to individual sheets 4a, from which the stent 50, shown in perspective view in fig. 8, is made.
  • the fibers are not distributed equally but according to a pattern of mutual parallel lines which include an angle with the boundaries of the sheet 44, such as shown in fig. 9, according to which the sheet 42 is provided with a pattern of strips 54 in which metallic fibers are embedded in the starting material.
  • a stent as shown in fig. 10 and indicated therein with reference numeral 56, made from such a sheet 54 has strips 60 which run obliquely over the outer surface 58 and in which the metallic fibers, which give the stent 56 its strength, are embedded in the material.
  • the sleeve is irradiated from within with UV radiation and practically the whole inner surface will then be irradiated equally. 7
  • the stent When the fibers are prepared in such a way that they emit radio-active radiation the stent also has a therapeutic action.
  • a stent in the way as shown schematically and in perspective view in fig. 11: a sleeve 62 from normal fiber material which has none or only a very small percentage of metallic fibers supports, on the outer surface 64 thereof, a helically wound strip 66 which is made of sheet material, soaked with curing plastics and having therein a certain concentration metallic fibers.
  • a sleeve 62 from normal fiber material which has none or only a very small percentage of metallic fibers supports, on the outer surface 64 thereof, a helically wound strip 66 which is made of sheet material, soaked with curing plastics and having therein a certain concentration metallic fibers.
  • the irradiation of the curing plastics will take place starting from the center of the core so that the base layer 64 will cure swiftly and uniformly; however after this layer 24 sufficient UV radiation reaches the strip 26 to initiate the curing thereof.
  • This embodiment has the advantage that one can choose the composition of the plastics present in the strips 66 in such a way that the curing of the basic core 64 and the strips 66 occurs equally fast.
  • the aspect discussed above according to which the fibers are distributed strip-like in the basic material can also be realised in the way as shown in fig. 12.
  • the fibers will be made generally by drawing wire-shaped starting material and in the known manner they are then available in bundles; from such a bundle of fibers smaller bundles are made which are embedded with predetermined mutual distances in the pulp material.
  • Fig. 12 shows a part of a pulp bed indicated with reference numeral 90 ; with predetermined mutual distances d fiber bundles 92 are embedded therein. Finally one obtains a starting material which is reinforced in a strip-like manner and from which stents having the configuration according to fig. 4 can be made.
  • Fig. 13 shows a fiber material 80 having therein elongate fibers 82 which are all directed in the same direction indicated by the arrow 84.
  • a part 80a is separated therefrom, from which part finally a cylindrical stent 86 according to fig. 8 is made, all fibers 88 therein will be oriented in the circumferential direction. In this way this element has an increased radial strength.
  • this stent can be coated with the commercially available 8
  • chromeflex ® , whereafter the whole is baked at a suitable temperature. This results in a biocompatible outer surface so that the material can be used without problems in a body vessel.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Composite Materials (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mechanical Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Rigid Pipes And Flexible Pipes (AREA)
  • Prostheses (AREA)
  • Heating, Cooling, Or Curing Plastics Or The Like In General (AREA)
PCT/NL1999/000035 1998-01-22 1999-01-20 A method for making an extensible stent from sheet material Ceased WO1999037243A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000528233A JP2002500921A (ja) 1998-01-22 1999-01-20 シート材料から伸長可能なステントを作成する方法
DE69926603T DE69926603T2 (de) 1998-01-22 1999-01-20 Verfahren zur herstellung eines aus bandförmigen material, ausdehnbaren stents
AU19865/99A AU1986599A (en) 1998-01-22 1999-01-20 A method for making an extensible stent from sheet material
EP99900719A EP1049419B1 (en) 1998-01-22 1999-01-20 A method for making an extensible stent from sheetmaterial

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1008093 1998-01-22
NL1008093A NL1008093C2 (nl) 1998-01-22 1998-01-22 Velvormig materiaal, werkwijze voor het vervaardigen daarvan en hulsvormig versterkingselement gevormd onder toepassing van dit materiaal.

Publications (1)

Publication Number Publication Date
WO1999037243A1 true WO1999037243A1 (en) 1999-07-29

Family

ID=19766390

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL1999/000035 Ceased WO1999037243A1 (en) 1998-01-22 1999-01-20 A method for making an extensible stent from sheet material

Country Status (6)

Country Link
EP (1) EP1049419B1 (https=)
JP (1) JP2002500921A (https=)
AU (1) AU1986599A (https=)
DE (1) DE69926603T2 (https=)
NL (1) NL1008093C2 (https=)
WO (1) WO1999037243A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021106A1 (en) * 1999-09-22 2001-03-29 Impra, Inc. Radioactive graft or cuff
NL1023389C2 (nl) 2003-05-12 2004-11-15 Hendrik Glastra Werkwijze voor het vormen van een uit een weefsel van elkaar kruisende draden opgebouwd driedimensioneel, hol product, product verkregen onder toepassing van deze werkwijze en uitgaande daarvan verkregen lichaamsvatprothese.
US7993391B2 (en) 2002-08-28 2011-08-09 Boston Scientific Scimed, Inc. Medical devices and methods of making the same

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2115776A (en) * 1982-03-02 1983-09-14 Ontario Research Foundation Implantable material
US4997703A (en) * 1987-10-13 1991-03-05 Basf Aktiengesellschaft Molding material containing fillers
FR2694688A1 (fr) * 1992-08-11 1994-02-18 Novadis Sarl Prothèse tubulaire expansible.
GB2270264A (en) * 1992-09-02 1994-03-09 Ellis Dev Ltd Palliative stent and insertion device therefor
US5397365A (en) * 1990-06-01 1995-03-14 E. I. Du Pont De Nemours And Company Composite orthopedic implant with modulus variations
EP0689807A2 (en) * 1994-06-27 1996-01-03 Advanced Cardiovascular Systems, Inc. Biodegradable mesh-and-film stent
EP0695626A2 (en) * 1994-08-04 1996-02-07 Teijin Limited Process for the production of composite molded article
EP0737453A2 (en) * 1990-05-18 1996-10-16 STACK, Richard S. Intraluminal stent
EP0815760A2 (en) * 1993-04-16 1998-01-07 Minnesota Mining And Manufacturing Company Orthopedic casting material

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338588A (en) * 1991-07-19 1994-08-16 Ticom Corporation Method of making reinforced structural composite assemblies and assembly produced thereby
US5591199A (en) * 1995-06-07 1997-01-07 Porter; Christopher H. Curable fiber composite stent and delivery system
NL1003178C2 (nl) * 1996-05-21 1997-11-25 Cordis Europ Buisvormige prothese van uithardbaar materiaal.

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2115776A (en) * 1982-03-02 1983-09-14 Ontario Research Foundation Implantable material
US4997703A (en) * 1987-10-13 1991-03-05 Basf Aktiengesellschaft Molding material containing fillers
EP0737453A2 (en) * 1990-05-18 1996-10-16 STACK, Richard S. Intraluminal stent
US5397365A (en) * 1990-06-01 1995-03-14 E. I. Du Pont De Nemours And Company Composite orthopedic implant with modulus variations
FR2694688A1 (fr) * 1992-08-11 1994-02-18 Novadis Sarl Prothèse tubulaire expansible.
GB2270264A (en) * 1992-09-02 1994-03-09 Ellis Dev Ltd Palliative stent and insertion device therefor
EP0815760A2 (en) * 1993-04-16 1998-01-07 Minnesota Mining And Manufacturing Company Orthopedic casting material
EP0689807A2 (en) * 1994-06-27 1996-01-03 Advanced Cardiovascular Systems, Inc. Biodegradable mesh-and-film stent
EP0695626A2 (en) * 1994-08-04 1996-02-07 Teijin Limited Process for the production of composite molded article

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021106A1 (en) * 1999-09-22 2001-03-29 Impra, Inc. Radioactive graft or cuff
US7993391B2 (en) 2002-08-28 2011-08-09 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
NL1023389C2 (nl) 2003-05-12 2004-11-15 Hendrik Glastra Werkwijze voor het vormen van een uit een weefsel van elkaar kruisende draden opgebouwd driedimensioneel, hol product, product verkregen onder toepassing van deze werkwijze en uitgaande daarvan verkregen lichaamsvatprothese.

Also Published As

Publication number Publication date
DE69926603T2 (de) 2006-06-01
JP2002500921A (ja) 2002-01-15
AU1986599A (en) 1999-08-09
DE69926603D1 (de) 2005-09-15
EP1049419A1 (en) 2000-11-08
EP1049419B1 (en) 2005-08-10
NL1008093C2 (nl) 1999-07-26

Similar Documents

Publication Publication Date Title
DE69627658T2 (de) Stent aus aushärtbarer faserzusammensetzung sowie zugehöriges einführsystem
DE69934990T2 (de) Verfahren zur Übertragung radioaktiver Stoffe auf Stents in der Angioplastie und Bausatz
US5100429A (en) Endovascular stent and delivery system
CN103948460B (zh) 可扩展的滑动和锁定支架
US6048299A (en) Radiation delivery catheter
US7020947B2 (en) Metal wire with filaments for biomedical applications
DE69326455T2 (de) Arzneigeräte für die Behandlung von Blutgefässen mittels ionisierungsbestrahlung
DE60217878T2 (de) Expandierbare medizinische Vorrichtung zur Abgabe eines Heilmittels
DE19807727B4 (de) Radioaktiver Ballon für ein Ballon-Dilatations-Kathetersystem und Verfahren zu dessen Herstellung
EP3337562B1 (en) Radioactive stent
CA2517444A1 (en) Products and methods for brachytherapy
WO2001093778A1 (en) A device for delivering a therapeutic dosage
US10058436B2 (en) Radiopaque marker for bioresorbable stents
EP1049419B1 (en) A method for making an extensible stent from sheetmaterial
EP2701757B1 (de) Implantierbare gefässstütze
EP2147688B1 (de) Endoprothese und Verfahren zur Herstellung derselben
US20060275341A1 (en) Thin foam coating comprising discrete, closed-cell capsules
JP2003509156A (ja) 放射性グラフト又はカフ
EP1475053A1 (de) Verfahren zur Herstellung eines medizinischen Implantates sowie ein auf diese Weise hergestelltes Implantat
US20170340899A1 (en) Radioactive stent
DE69331289T9 (de) Arzneigeraete fuer die behandlung von blutgefaessen mittels ionisierungsbestrahlung
DE10320772A1 (de) Verfahren zur Abgabe von an einem Stent angebrachten Wirkstoff an einen menschlichen oder tierischen Körper und Stent hierfür

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09621749

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1999900719

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999900719

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1999900719

Country of ref document: EP